These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2779072)

  • 21. [Incidence of dyslipoproteinemias in familial epilepsy].
    Havlová M; Sobra J
    Cesk Pediatr; 1987 Dec; 42(12):707-11. PubMed ID: 3442851
    [No Abstract]   [Full Text] [Related]  

  • 22. [Localization of vessel lesions in arteriosclerosis and blood lipid composition].
    Lipovetskiĭ BM; Vinogradova TV
    Ter Arkh; 2002; 74(2):55-7. PubMed ID: 11899828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Contrast-unloading week in the complex therapy of patients with metabolic-alimentary obesity and its effect on changes in body weight and lipid metabolism indices].
    Loĭko VI; Baketova NN; Lebedeva EA; Kolmakov VN; Skovorodnikova ES
    Vopr Pitan; 1979; (5):30-3. PubMed ID: 516598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Genetic factors in ischemic heart disease].
    Slavchev S
    Vutr Boles; 1986; 25(3):12-9. PubMed ID: 3532554
    [No Abstract]   [Full Text] [Related]  

  • 25. Platelets intravascular coagulation and fibrinolysis in hyperlipidaemias: relationship to thrombo-embolic complications.
    Carvalho AC; Lees RS
    Acta Med Scand Suppl; 1980; 642():101-12. PubMed ID: 6935936
    [No Abstract]   [Full Text] [Related]  

  • 26. Behaviour of uricemia in hyperlipoproteinemic subjects.
    Zdrenghea D; Marta D; Constantinescu M; Cucuianu M
    Med Interne; 1980; 18(4):385-90. PubMed ID: 7455583
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Familial disorders of lipid metabolism in childhood].
    Herrmann W; Biermann J
    Z Arztl Fortbild (Jena); 1986; 80(17):725-8. PubMed ID: 3811401
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical picture of familial hypercholesterolemia and ischemic heart disease in childhood].
    Kliorin AI; Mogil'nyĭ IA; Lazarev MV
    Pediatriia; 1986 Aug; (8):64-6. PubMed ID: 3763353
    [No Abstract]   [Full Text] [Related]  

  • 29. Plasma lipid levels and coronary heart disease in adult relatives of newborns with normal and elevated cord blood lipids.
    Goldstein JL; Albers JJ; Schrott HG; Hazzard WR; Bierman EL; Motulsky AG
    Am J Hum Genet; 1974 Nov; 26(6):727-35. PubMed ID: 4440681
    [No Abstract]   [Full Text] [Related]  

  • 30. [Physical work capacity of ischemic heart disease patients with various types of hyperlipoproteinemias].
    Zadionchenko VS; Kopalova SM
    Kardiologiia; 1980 Aug; 20(8):75-9. PubMed ID: 7412102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetics of coronary heart disease and its risk factors.
    Berg K
    Prog Clin Biol Res; 1985; 177():351-74. PubMed ID: 3160046
    [No Abstract]   [Full Text] [Related]  

  • 32. Familial aggregation of lipids and lipoproteins and early identification of dyslipoproteinemia. The Collaborative Lipid Research Clinics Family Study.
    Morrison JA; Namboodiri K; Green P; Martin J; Glueck CJ
    JAMA; 1983 Oct; 250(14):1860-8. PubMed ID: 6620483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum lipids and smoking habit in first degree relatives of patients of ischaemic heart disease.
    Vajpayee A; Chadda VS; Jain NC; Mishra SN; Sulemani AA; Singhvi DR
    Indian Heart J; 1981; 33(6):274-6. PubMed ID: 7341399
    [No Abstract]   [Full Text] [Related]  

  • 34. [Data on repeated studies on the blood lipid levels in evaluating the severity of chronic ischemic heart disease].
    Shipilova TV
    Kardiologiia; 1983 Feb; 23(2):85-8. PubMed ID: 6842955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apolipoprotein E phenotype frequency in type II diabetic patients with different forms of hyperlipoproteinemia.
    Parhofer KG; Richter WO; Schwandt P
    Horm Metab Res; 1990 Nov; 22(11):589-94. PubMed ID: 2272605
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Apolipoproteins - an important diagnostic indicator in the evaluation of coronary disease risk].
    Naruszewicz M; Nowicka G
    Pol Arch Med Wewn; 1980 Aug; 64(2):161-6. PubMed ID: 7433154
    [No Abstract]   [Full Text] [Related]  

  • 37. [Primary hyperlipoproteinemia in its clinical and laboratory aspects. VII. Phonoangiographic study].
    Szmatłoch E; Olejak B; Gregorczyk J; Pieczul-Mróz J; Brzeźniak R; Ansilewski K; Jagła A; Kutrzeba J
    Przegl Lek; 1984; 41(2):213-6. PubMed ID: 6739839
    [No Abstract]   [Full Text] [Related]  

  • 38. [Coronary artery disease in heterozygous familial hypercholesterolemia (author's transl)].
    Hirobe K; Hara H; Kameda K; Tokunaga K; Kubo M; Sudo H; Matsuzawa Y; Ishikawa K; Tarui S; Yamamoto A; Nabu S; Fujimoto K
    Kokyu To Junkan; 1982 Jan; 30(1):87-93. PubMed ID: 7079619
    [No Abstract]   [Full Text] [Related]  

  • 39. [Platelet half-life in patients with primary hyperlipoproteinemia type IIa, IIb, and IV according to Fredrickson with and without clinical signs of atherosclerosis].
    Jäger E; Sinzinger H; Widhalm K; Kaliman J; Höfer R
    Wien Klin Wochenschr; 1982 Sep; 94(16):421-5. PubMed ID: 7147981
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Fibrinolytic capacity after exertion in atherogenic hyperlipoproteinemias].
    Zdrenghea D; Mărcuşu C; Cucuianu M; Rentsch S
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1979; 31(5):435-40. PubMed ID: 44567
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.